| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.02 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |